Brief: Amicus Therapeutics and ARYA Sciences Acquisition Corp IV Announce Formation Of A Next-Generation Genetic Medicine Company

Adagio Medical Holdings

29/09/2021 11:54

Sept 29 (Reuters) - AMICUS THERAPEUTICS INC:
    * AMICUS THERAPEUTICS, WHICH IS FORMING A NEW CO CARITAS,
SAYS
JOHN F. CROWLEY WILL LEAD CARITAS AS CHAIRMAN, CEO 
    * AMICUS THERAPEUTICS INC - AMICUS GENE THERAPY BUSINESS
WILL BE
ACQUIRED BY ARYA SCIENCES ACQUISITION CORP IV
    * AMICUS THERAPEUTICS INC - TRANSACTION WILL RESULT IN TWO
INDEPENDENT PUBLICLY TRADED COMPANIES WITH ATTRACTIVE
STAND-ALONE INVESTMENT PROFILES
    * AMICUS THERAPEUTICS INC -  WILL BECOME LARGEST SHAREHOLDER
IN
CARITAS WITH ABOUT 36% OWNERSHIP STAKE
    * AMICUS THERAPEUTICS INC -  WILL RETAIN CO-DEVELOPMENT AND
COMMERCIALIZATION RIGHTS TO FABRY AND POMPE GENE THERAPY
PROGRAMS
    * AMICUS THERAPEUTICS INC - CURRENT AMICUS CHAIRMAN AND CEO
JOHN
F. CROWLEY WILL LEAD CARITAS AS CHAIRMAN AND CEO
    * AMICUS THERAPEUTICS INC - CURRENT AMICUS PRESIDENT AND
CHIEF
OPERATING OFFICER BRADLEY CAMPBELL WILL BE NAMED AS CHIEF
EXECUTIVE OFFICER OF AMICUS
    * AMICUS THERAPEUTICS INC -  SYNDICATE OF HEALTHCARE
BIOTECHNOLOGY
INVESTORS HAVE AGREED TO A PRIVATE INVESTMENT IN AMICUS OF
APPROXIMATELY $200 MILLION
    * AMICUS THERAPEUTICS INC - WILL ALSO INVEST $50 MILLION IN
CASH
IN CARITAS IN EXCHANGE FOR ADDITIONAL EQUITY IN CARITAS

Further company coverage:  FOLD.O 

 ((Reuters.Briefs@thomsonreuters.com;))